Dermira Inc. (DERM)

8.04
0.18 2.25
NASDAQ : Health Technology
Prev Close 8.23
Open 8.27
Day Low/High 7.93 / 8.30
52 Wk Low/High 5.25 / 15.48
Volume 1.40M
Avg Volume 993.40K
Exchange NASDAQ
Shares Outstanding 54.40M
Market Cap 380.01M
EPS -5.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Dermira Reports Third Quarter 2019 Financial Results And Provides Corporate Update

Dermira Reports Third Quarter 2019 Financial Results And Provides Corporate Update

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today reported financial...

Dermira To Report Third Quarter 2019 Results And Host Conference Call On Tuesday, November 5, 2019

Dermira To Report Third Quarter 2019 Results And Host Conference Call On Tuesday, November 5, 2019

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of people living with chronic skin conditions, will report financial...

First Week Of DERM June 2020 Options Trading

First Week Of DERM June 2020 Options Trading

Investors in Dermira Inc saw new options begin trading this week, for the June 2020 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Dermira Presents Data From Phase 2b Study Of Lebrikizumab In Patients With Atopic Dermatitis At Fall Clinical Dermatology Conference

Dermira Presents Data From Phase 2b Study Of Lebrikizumab In Patients With Atopic Dermatitis At Fall Clinical Dermatology Conference

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that...

Dermira To Present Data From Phase 2b Study Of Lebrikizumab In Patients With Atopic Dermatitis At Fall Clinical Dermatology Conference

Dermira To Present Data From Phase 2b Study Of Lebrikizumab In Patients With Atopic Dermatitis At Fall Clinical Dermatology Conference

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that...

Dermira Announces Initiation Of Phase 3 Program Evaluating Lebrikizumab In Patients With Moderate-to-Severe Atopic Dermatitis

Dermira Announces Initiation Of Phase 3 Program Evaluating Lebrikizumab In Patients With Moderate-to-Severe Atopic Dermatitis

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced dosing of...

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that on...

Interesting DERM Put And Call Options For January 2020

Interesting DERM Put And Call Options For January 2020

Investors in Dermira Inc saw new options begin trading today, for the January 2020 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 107 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Dermira To Participate In The 2019 Cantor Global Healthcare Conference

Dermira To Participate In The 2019 Cantor Global Healthcare Conference

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that...

DERM Crosses Above Key Moving Average Level

DERM Crosses Above Key Moving Average Level

In trading on Wednesday, shares of Dermira Inc crossed above their 200 day moving average of $9.33, changing hands as high as $9.48 per share. Dermira Inc shares are currently trading up about 4.1% on the day.

Dermira To Participate In Upcoming Investor Conferences

Dermira To Participate In Upcoming Investor Conferences

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that the...

Dermira Reports Second Quarter 2019 Financial Results And Provides Corporate Update

Dermira Reports Second Quarter 2019 Financial Results And Provides Corporate Update

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today reported financial...

Relative Strength Alert For Dermira

Relative Strength Alert For Dermira

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting DERM Put And Call Options For August 16th

Interesting DERM Put And Call Options For August 16th

Investors in Dermira Inc saw new options become available this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DERM options chain for the new August 16th contracts and identified one put and one call contract of particular interest.

Dermira To Report Second Quarter 2019 Results And Host Conference Call On Wednesday, August 7, 2019

Dermira To Report Second Quarter 2019 Results And Host Conference Call On Wednesday, August 7, 2019

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of people living with chronic skin conditions, will report financial...

Rally Runs Low on Fuel: Cramer's 'Mad Money' Recap (Tuesday 6/11/19)

Rally Runs Low on Fuel: Cramer's 'Mad Money' Recap (Tuesday 6/11/19)

Cramer says rallies need fuel, and without it, we end up with what we got Tuesday: a soggy session that reminds us stocks can go down, too.

Yeti Holdings, Canopy Growth, Dermira: 'Mad Money' Lightning Round

Yeti Holdings, Canopy Growth, Dermira: 'Mad Money' Lightning Round

Jim Cramer takes a look at Yeti Holdings, Canopy Growth, Dermira, Daktronics, TherapeuticsMD, Rite Aid, Genpact and California Water Services.

Dermira To Present At The Raymond James Life Sciences And MedTech Conference

Dermira To Present At The Raymond James Life Sciences And MedTech Conference

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that...

Dermira Advances on Analyst Upgrade to Buy

Dermira Advances on Analyst Upgrade to Buy

Shares of Dermira climb after Mizuho upgrades shares of the biopharmaceutical company to buy from neutral.

Dermira Reports First Quarter 2019 Financial Results And Provides Corporate Update

Dermira Reports First Quarter 2019 Financial Results And Provides Corporate Update

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today reported financial...

Dermira To Report First Quarter 2019 Results And Host Conference Call On Tuesday, May 7, 2019

Dermira To Report First Quarter 2019 Results And Host Conference Call On Tuesday, May 7, 2019

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of people living with chronic skin conditions, will report financial...

Interesting DERM Put And Call Options For May 17th

Interesting DERM Put And Call Options For May 17th

Investors in Dermira Inc saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DERM options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

Dermira To Present At The 18th Annual Needham Healthcare Conference

Dermira To Present At The 18th Annual Needham Healthcare Conference

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that...

Dermira Shares Rocket After Successful Phase II Eczema Treatment Study

Dermira Shares Rocket After Successful Phase II Eczema Treatment Study

Dermira shares doubled Monday after the group said its new eczema treatment passed a key study in adult patients with moderate-to-severe atopic dermatitis.

First Week Of September 20th Options Trading For Dermira (DERM)

First Week Of September 20th Options Trading For Dermira (DERM)

Investors in Dermira Inc saw new options begin trading this week, for the September 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 218 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Interesting DERM Put And Call Options For April 18th

Interesting DERM Put And Call Options For April 18th

Investors in Dermira Inc saw new options become available today, for the April 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 85 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Dermira Becomes Oversold (DERM)

Dermira Becomes Oversold (DERM)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TheStreet Quant Rating: D- (Sell)